Suppr超能文献

趋化性细胞因子与炎症。淋巴细胞和单核细胞趋化因子ELCF、MCAF及IL-8的生物学特性。

Chemotactic cytokines and inflammation. Biological properties of the lymphocyte and monocyte chemotactic factors ELCF, MCAF and IL-8.

作者信息

Zachariae C O

机构信息

Department of Dermatology, Marselisborg Hospital, University of Aarhus, Denmark.

出版信息

Acta Derm Venereol Suppl (Stockh). 1993;181:1-37.

PMID:7901957
Abstract

This thesis discusses the phenotypic characteristics of different inflammatory dermatological diseases and sets this into context with the specific chemotactic ability of different cytokines. It further discusses the biological properties of different chemotactic cytokines and their relevance in certain inflammatory diseases. The term chemotaxis was introduced in 1884 by Pfeffer, who described it as directional migration of leukocytes along a gradient. Regular studies of chemotaxis were, however, not possible until 1962 when Boyden developed the chemotaxis chamber technique. This test has since then been improved, and it is now possible to define and characterize chemoattractants and examine the special chemotactic behavior of leukocytes. We investigated T lymphocyte responses towards different chemoattractants using a modified Boyden chamber technique and found that approximately 50% of normal individuals have cells which respond whereas T-cells from the remaining persons did not respond. We therefore chose human T lymphocytic cell lines as target cells for chemotaxis screening to avoid inter-individual variations among donors. T lymphocytic infiltrates dominated by CD4+, CD45R0+ memory T cells are characteristic for many dermatological inflammatory diseases. We have therefore performed experiments to evaluate whether an earlier described epidermal lymphocyte chemotactic factor (ELCF) from skin overlying a tuberculin skin reaction in addition with other cytokines specifically attracts different subsets of lymphocytes. ELCF which probably reflects a mixture of different epidermal T lymphocyte chemotactic factors rather than a single factor was shown to specifically attract CD4+, CD45R0+ T lymphocytes in contrast to fMLP, IL-8, C5a and LTB4, which induced equal chemotaxis for both CD4+ and CD8+ T lymphocytes. A newly described inhibitory cytokine IL-10 selectively attracted the CD8+ subpopulation of T lymphocytes, and it is suggested that IL-10 could be an important factor in the downregulation of an inflammatory response. The recently discovered neutrophil chemotactic and activating factor IL-8 has been shown to be chemotactic for T lymphocytes as well. It belongs to a family of 8,000-10,000 KDa peptides of which a monocyte chemotactic and activating factor MCAF is also a member. We showed that mRNA for IL-8 could be expressed in highly purified T lymphocytes only upon stimulation with ionomycin and PHA or PMA and PHA, and to a lesser extent PMA and IL-2. This is consistent with other reports of T lymphocytes requiring two signals for cytokine production. We showed that it was only the CD4+ subpopulation of the T lymphocytes that expressed IL-8 mRNA.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

本论文讨论了不同炎症性皮肤病的表型特征,并结合不同细胞因子的特定趋化能力进行阐述。论文进一步探讨了不同趋化细胞因子的生物学特性及其在某些炎症性疾病中的相关性。趋化作用这一术语于1884年由普费弗提出,他将其描述为白细胞沿梯度的定向迁移。然而,直到1962年博伊登开发出趋化作用室技术后,才能够对趋化作用进行常规研究。从那时起,这项测试不断改进,现在可以定义和表征趋化因子,并研究白细胞的特殊趋化行为。我们使用改良的博伊登室技术研究了T淋巴细胞对不同趋化因子的反应,发现约50%的正常个体的细胞有反应,而其余个体的T细胞无反应。因此,我们选择人类T淋巴细胞系作为趋化作用筛选的靶细胞,以避免供体之间的个体差异。以CD4 +、CD45R0 +记忆T细胞为主的T淋巴细胞浸润是许多皮肤炎症性疾病的特征。因此,我们进行了实验,以评估先前描述的来自结核菌素皮肤反应上方皮肤的表皮淋巴细胞趋化因子(ELCF)与其他细胞因子一起是否能特异性吸引不同亚群的淋巴细胞。ELCF可能反映了不同表皮T淋巴细胞趋化因子的混合物,而不是单一因子,与fMLP、IL - 8、C5a和LTB4不同,ELCF被证明能特异性吸引CD4 +、CD45R0 + T淋巴细胞,而fMLP、IL - 8、C5a和LTB4对CD4 +和CD8 + T淋巴细胞诱导的趋化作用相同。一种新描述的抑制性细胞因子IL - 10选择性地吸引T淋巴细胞的CD8 +亚群,提示IL - 10可能是炎症反应下调的一个重要因素。最近发现的中性粒细胞趋化和激活因子IL - 8也已被证明对T淋巴细胞有趋化作用。它属于一个8000 - 10000 KDa肽的家族,单核细胞趋化和激活因子MCAF也是其成员。我们发现,只有在用离子霉素和PHA或PMA和PHA刺激后,高度纯化的T淋巴细胞中才能表达IL - 8的mRNA,在用PMA和IL - 2刺激时表达程度较低。这与其他关于T淋巴细胞产生细胞因子需要两个信号的报道一致。我们发现只有T淋巴细胞的CD4 +亚群表达IL - 8 mRNA。(摘要截选至400字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验